000 | 00995 a2200265 4500 | ||
---|---|---|---|
005 | 20250517130358.0 | ||
264 | 0 | _c20170313 | |
008 | 201703s 0 0 eng d | ||
022 | _a1473-4893 | ||
024 | 7 |
_a10.7861/clinmedicine.16-6-565 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKumar, Kartik | |
245 | 0 | 0 |
_aClinical implications of the global multidrug-resistant tuberculosis epidemic. _h[electronic resource] |
260 |
_bClinical medicine (London, England) _cDec 2016 |
||
300 |
_a565-570 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
650 | 0 | 4 | _aGlobal Health |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xcomplications |
650 | 0 | 4 | _aUnited Kingdom |
700 | 1 | _aAbubakar, Ibrahim | |
773 | 0 |
_tClinical medicine (London, England) _gvol. 16 _gno. 6 _gp. 565-570 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.7861/clinmedicine.16-6-565 _zAvailable from publisher's website |
999 |
_c26675371 _d26675371 |